Oncology & Cancer

Drug kills cancer cells by restoring faulty tumor suppressor

A new study describes a compound that selectively kills cancer cells by restoring the structure and function of one of the most commonly mutated proteins in human cancer, the "tumor suppressor" p53. The research, published ...

Diseases, Conditions, Syndromes

New Chlamydia test shows type of infection

A new Chlamydia test can quickly and easily demonstrate the subtype (serovar) of the bacterium Chlamydia trachomatis a person is infected with. This has important clinical implications, because some Chlamydia subtypes, that ...

Oncology & Cancer

'Junk DNA' affects inherited cancer risk

A person's risk of developing cancer is affected by genetic variations in regions of DNA that don't code for proteins, previously dismissed as 'junk DNA', according to new research published in the British Journal of Cancer ...

Oncology & Cancer

Engineering T cells to attack cancer broadly

Through T cell engineering, researchers at Virginia Commonwealth University Massey Cancer Center show that it's possible to arrest tumor growth for a variety of cancers and squash the spread of cancer to other tissues. This ...

page 2 from 18